H-Cys-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-NH2
Internal ID | 7032bcc7-1d0e-4938-bcc4-625fbcbbf8ae |
Taxonomy | Organic Polymers > Polypeptides |
IUPAC Name | (4S)-4-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-3-sulfanylpropanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]hexanoyl]amino]-3-methylbutanoyl]amino]-5-[[(2S)-1-[(2S)-2-carbamoylpyrrolidin-1-yl]-3-carboxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid |
SMILES (Canonical) | CC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)O)C(=O)N1CCCC1C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C2CCCN2C(=O)C(CS)N |
SMILES (Isomeric) | CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CS)N |
InChI | InChI=1S/C57H103N19O15S/c1-32(2)45(54(89)72-39(21-22-43(77)78)51(86)73-40(30-44(79)80)56(91)75-28-12-19-41(75)46(63)81)74-52(87)37(17-6-10-26-61)69-50(85)38(18-11-27-66-57(64)65)70-48(83)35(15-4-8-24-59)67-47(82)34(14-3-7-23-58)68-49(84)36(16-5-9-25-60)71-53(88)42-20-13-29-76(42)55(90)33(62)31-92/h32-42,45,92H,3-31,58-62H2,1-2H3,(H2,63,81)(H,67,82)(H,68,84)(H,69,85)(H,70,83)(H,71,88)(H,72,89)(H,73,86)(H,74,87)(H,77,78)(H,79,80)(H4,64,65,66)/t33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,45-/m0/s1 |
InChI Key | FDLNDXHQLYMFJR-VDPSYGMHSA-N |
Popularity | 0 references in papers |
Molecular Formula | C57H103N19O15S |
Molecular Weight | 1326.60 g/mol |
Exact Mass | 1325.76017483 g/mol |
Topological Polar Surface Area (TPSA) | 587.00 Ų |
XlogP | -10.50 |
Atomic LogP (AlogP) | -5.85 |
H-Bond Acceptor | 20 |
H-Bond Donor | 19 |
Rotatable Bonds | 46 |
There are no found synonyms. |

Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | - | 0.5815 | 58.15% |
Caco-2 | - | 0.8578 | 85.78% |
Blood Brain Barrier | - | 0.9000 | 90.00% |
Human oral bioavailability | - | 0.6143 | 61.43% |
Subcellular localzation | Mitochondria | 0.5113 | 51.13% |
OATP2B1 inhibitior | - | 1.0000 | 100.00% |
OATP1B1 inhibitior | + | 0.8774 | 87.74% |
OATP1B3 inhibitior | + | 0.9405 | 94.05% |
MATE1 inhibitior | - | 0.8200 | 82.00% |
OCT2 inhibitior | - | 0.7250 | 72.50% |
BSEP inhibitior | + | 0.9139 | 91.39% |
P-glycoprotein inhibitior | + | 0.7425 | 74.25% |
P-glycoprotein substrate | + | 0.8005 | 80.05% |
CYP3A4 substrate | + | 0.6993 | 69.93% |
CYP2C9 substrate | - | 0.8008 | 80.08% |
CYP2D6 substrate | - | 0.8231 | 82.31% |
CYP3A4 inhibition | - | 0.9562 | 95.62% |
CYP2C9 inhibition | - | 0.9054 | 90.54% |
CYP2C19 inhibition | - | 0.8428 | 84.28% |
CYP2D6 inhibition | - | 0.9272 | 92.72% |
CYP1A2 inhibition | - | 0.8739 | 87.39% |
CYP2C8 inhibition | - | 0.6032 | 60.32% |
CYP inhibitory promiscuity | - | 0.9880 | 98.80% |
UGT catelyzed | - | 0.0000 | 0.00% |
Carcinogenicity (binary) | - | 0.8700 | 87.00% |
Carcinogenicity (trinary) | Non-required | 0.6091 | 60.91% |
Eye corrosion | - | 0.9859 | 98.59% |
Eye irritation | - | 0.8960 | 89.60% |
Skin irritation | - | 0.7522 | 75.22% |
Skin corrosion | - | 0.9193 | 91.93% |
Ames mutagenesis | - | 0.5300 | 53.00% |
Human Ether-a-go-go-Related Gene inhibition | + | 0.6537 | 65.37% |
Micronuclear | + | 0.7900 | 79.00% |
Hepatotoxicity | + | 0.5821 | 58.21% |
skin sensitisation | - | 0.8463 | 84.63% |
Respiratory toxicity | + | 0.9000 | 90.00% |
Reproductive toxicity | + | 0.8111 | 81.11% |
Mitochondrial toxicity | + | 0.7375 | 73.75% |
Nephrotoxicity | + | 0.6928 | 69.28% |
Acute Oral Toxicity (c) | III | 0.5907 | 59.07% |
Estrogen receptor binding | + | 0.6549 | 65.49% |
Androgen receptor binding | + | 0.6989 | 69.89% |
Thyroid receptor binding | + | 0.5822 | 58.22% |
Glucocorticoid receptor binding | + | 0.6399 | 63.99% |
Aromatase binding | + | 0.7340 | 73.40% |
PPAR gamma | + | 0.7171 | 71.71% |
Honey bee toxicity | - | 0.8314 | 83.14% |
Biodegradation | - | 0.8000 | 80.00% |
Crustacea aquatic toxicity | - | 0.5600 | 56.00% |
Fish aquatic toxicity | - | 0.5862 | 58.62% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.40% | 98.33% |
CHEMBL3468 | P55210 | Caspase-7 | 99.31% | 95.68% |
CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 99.14% | 94.66% |
CHEMBL204 | P00734 | Thrombin | 99.07% | 96.01% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.03% | 96.09% |
CHEMBL2581 | P07339 | Cathepsin D | 98.89% | 98.95% |
CHEMBL4801 | P29466 | Caspase-1 | 98.86% | 96.85% |
CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.71% | 100.00% |
CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 98.28% | 96.67% |
CHEMBL237 | P41145 | Kappa opioid receptor | 97.73% | 98.10% |
CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 97.59% | 98.94% |
CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 97.47% | 93.10% |
CHEMBL3776 | Q14790 | Caspase-8 | 96.88% | 97.06% |
CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.45% | 96.67% |
CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 96.37% | 98.24% |
CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 96.23% | 82.69% |
CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 95.96% | 97.86% |
CHEMBL3837 | P07711 | Cathepsin L | 95.65% | 96.61% |
CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.44% | 96.47% |
CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 95.27% | 100.00% |
CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 94.46% | 92.38% |
CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.29% | 96.03% |
CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.81% | 93.56% |
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 93.64% | 91.11% |
CHEMBL2334 | P42574 | Caspase-3 | 93.60% | 98.25% |
CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.77% | 99.17% |
CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.75% | 100.00% |
CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 92.51% | 99.77% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 92.32% | 96.00% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 92.04% | 94.45% |
CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 91.63% | 98.77% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 91.47% | 97.09% |
CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 91.11% | 90.71% |
CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 90.98% | 93.00% |
CHEMBL4822 | P56817 | Beta-secretase 1 | 90.57% | 97.35% |
CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 90.39% | 94.00% |
CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 90.32% | 90.08% |
CHEMBL4581 | P52732 | Kinesin-like protein 1 | 90.26% | 93.18% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.85% | 91.19% |
CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 89.77% | 88.42% |
CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 88.90% | 95.52% |
CHEMBL236 | P41143 | Delta opioid receptor | 88.77% | 99.35% |
CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 88.66% | 95.00% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 87.77% | 95.50% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 87.54% | 95.89% |
CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 86.46% | 97.21% |
CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 85.91% | 97.64% |
CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 85.82% | 97.50% |
CHEMBL3018 | Q9Y5Y6 | Matriptase | 85.80% | 98.33% |
CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 85.36% | 96.28% |
CHEMBL221 | P23219 | Cyclooxygenase-1 | 85.27% | 90.17% |
CHEMBL4071 | P08311 | Cathepsin G | 85.01% | 94.64% |
CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 84.87% | 95.17% |
CHEMBL230 | P35354 | Cyclooxygenase-2 | 84.79% | 89.63% |
CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 84.79% | 93.33% |
CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 84.74% | 97.29% |
CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 84.52% | 94.33% |
CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 84.43% | 96.11% |
CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 84.30% | 96.00% |
CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 83.97% | 94.50% |
CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 83.48% | 95.27% |
CHEMBL5028 | O14672 | ADAM10 | 83.01% | 97.50% |
CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 82.88% | 98.00% |
CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 82.75% | 82.05% |
CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 82.72% | 83.14% |
CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 82.57% | 96.38% |
CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 82.34% | 97.50% |
CHEMBL2593 | P30419 | Peptide N-myristoyltransferase 1 | 82.28% | 93.45% |
CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 82.28% | 92.32% |
CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 82.13% | 93.03% |
CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 82.06% | 85.00% |
CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 82.05% | 95.89% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 81.87% | 95.56% |
CHEMBL3784 | Q09472 | Histone acetyltransferase p300 | 81.65% | 93.33% |
CHEMBL4374 | Q9Y5X4 | Photoreceptor-specific nuclear receptor | 81.58% | 85.00% |
CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 81.45% | 82.50% |
CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 81.23% | 97.23% |
CHEMBL3176 | O43603 | Galanin receptor 2 | 81.16% | 98.89% |
CHEMBL206 | P03372 | Estrogen receptor alpha | 80.63% | 97.64% |
CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 80.59% | 96.31% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 80.01% | 95.38% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Brassica juncea |